Mr. Seppo Orsila, Executive Chairman
Mr. Orsila returned to operational role in 2014 after 8 years at Nokia. He is sharing operational responsibilities with Dr. Uusimaa, President & CEO. Mr. Orsila is responsible for Marketing, Product Management, sales to selected customers and Business development. Mr. Orsila has 20 years of international leadership experience in sales, marketing, finance and product management. Mr. Orsila served at Modulight as CFO and VP Marketing (2000-2006). From 2006 to 2014 he worked at Nokia Mobile Phones (today Microsoft Mobile) last 4 years as CFO of the accessories business unit a.k.a. Nokia Gear. He has MBA from Helsinki School of Economics (2004) and Master of Science in semiconductor physics from Tampere University of Technology (1999).
Mr. Kalle Palomäki, Non-executive Director
Mr. Kalle Palomäki joined Modulight board in 2013. He has MBA from Helsinki School of Economics and Master in computer science from Tampere University of Technology. He has over 15 years international experience in telecommunications, mobile services and enterprise software. During his career, Kalle has acted in various B2B sales roles for several Nasdaq listed organizations, including Synopsys, PacketVideo, Adobe, and SSH Communications Security. In February 2013, Efecte Oy acquired RM5 Software Oy, where Kalle acted as the CEO. Currently Kalle works at Healthy Life Devices as President & CEO.
Dr. Petteri Uusimaa, President & Executive Director
PhD in semiconductor physics from Tampere University of Technology (TUT). Prior to joining Modulight Petteri held numerous manager positions in international research projects in which he managed relations to international funding companies as well as was the principal scientist in the programs. Since 1997 Petteri has been managing semiconductor sales to multinational companies and acted as a President & CEO of Modulight and Modulight board member since incorporating the company in 2000.
Mr. Jyrki Liljeroos, Non-executive Director
Mr. Liljeroos has a wide experience on pharmaceutical and healthcare industries, and business strategy. He has been the CEO and Executive Chairman of Santen Finland for 20 years. Mr. Liljeroos has also held various other positions in pharmaceutical industry, and he is among the very few foreign persons in a listed Japanese company’s top management board as a corporate officer.